HMGB1 and neoplasm: Tumor cells undergoing ICD release or express ICD‐related damage‐associated molecular patterns (DAMPs), such as calreticulin (CRT), high mobility group box‐1 protein (HMGB1), adenosine triphosphate (ATP), and interferon‐β (IFN‐β) [9, 10].